Position in PAHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$467,513
+$467,513 QoQ
Shares Held
14,889
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 207 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Derivatives in PAHC
reported options exposure · as of Jun 30, 2026CallValue
$251,200
CallShares
8,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. PAHC ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in PAHC
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $251,200 | 8,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $467,513 | 14,889 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $210,178 | 3,800 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,772,582 | 47,446 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $336,240 | 9,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $1,388,869 | 34,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,294,346 | 168,142 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $6,708 | 400 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $1,110,039 | 66,192 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $82,173 | 4,900 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $393,718 | 30,450 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $129,300 | 10,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $27,153 | 2,100 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $60,216 | 5,200 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $1,379,745 | 119,149 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $23,160 | 2,000 | Call | Defined | 2024-02-14 | |
| 2023-06-30 | $82,200 | 6,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $140,753 | 10,274 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $42,470 | 3,100 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $128,688 | 8,400 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $770,136 | 50,270 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $59,748 | 3,900 | Put | Defined | 2023-05-15 | |
| 2022-12-31 | $30,843 | 2,300 | Put | Defined | 2023-02-14 | |
| 2022-12-31 | $60,345 | 4,500 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $2,146,054 | 160,034 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $944,852 | 71,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $748,422 | 39,123 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,998,949 | 100,198 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,455,484 | 120,249 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,060,510 | 142,085 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,124,122 | 108,176 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $2,022,398 | 104,140 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $978,454 | 56,233 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $264,696 | 10,076 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,867,954 | 77,284 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||